4basebio AG: Implementation of the reverse stock split of 4basebio AG
4basebio AG: Implementation of the reverse stock split of 4basebio AG Heidelberg (pta007/22.02.2021/07:30) - 4basebio AG announces further details on the upcoming reverse stock split. On November 3, 2020, the Extraordinary General Meeting of 4basebio AG resolved to reduce the Company's share capital from EUR 51,733,386.00 divided into 51,733,386 no-par value bearer shares, by EUR 45,985,232.00 to EUR 5,748,154.00. The share capital of the Company shall be reduced in accordance with the provisions on the ordinary capital reduction pursuant to Sections 222 et seq. AktG (German Stock Corporation...